Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma

Clinical trial NCT06550921 · RECRUITING

Trial details

NCT number: NCT06550921
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma Oligometastasis Ablation Anti-PD1 Antibody Lenvatinib

Start date: 2024-08-01
Primary completion: 2026-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.